This is supported by previous research showing that a 25% dose reduction of insulin degludec on 5 consecutive days did not protect against hypoglycaemia during the first 48 h after exercise in people with type 1 diabetes [16]. The gene discussed is INS; the disease is type 1 diabetes mellitus.